Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
March-April 2014 Volume 2 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-April 2014 Volume 2 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection

  • Authors:
    • Lin Wang
    • Chunnan Zhao
    • Qunxin Peng
    • Jinfang Shi
    • Guohao Gu
  • View Affiliations / Copyright

    Affiliations: Department of Laboratory Medicine, Key Laboratory of Clinical Immunology of Jiangsu Province, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
  • Pages: 270-274
    |
    Published online on: January 7, 2014
       https://doi.org/10.3892/br.2014.217
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Chronic hepatitis B (CHB) is one of the most common types of infectious diseases worldwide. The interaction between hepatitis B virus (HBV) and the host immune response is vital for the clinical outcome of HBV infection. Costimulatory signals are key factors for the host immune response and play a critical role in innate immunity, particularly antiviral immunity. The aim of the present study was to investigate the correlation between the expression levels of costimulatory molecules and the different states of CHB infection, including the expression levels prior to and following treatment with antiviral agents. The expression levels of CD28, CTLA‑4, PD‑1, Tim‑3 and T‑cell subsets were determined by flow cytometry. The load of HBV DNA in the serum was detected by quantitative polymerase chain reaction and the serology markers, including HBeAg and alanine aminotransferase (ALT), were measured by conventional methods. Compared to the healthy control group, the expression levels of CD28 and CTLA‑4 on CD4 T cells prior to and following treatment with antiviral agents (the pre‑ and post‑treatment groups, respectively) were significantly decreased, while the expression levels of Tim‑3 on CD4 and CD8 T cells were significantly increased. In addition, the expression levels of PD‑1 on CD4 and CD8 T cells in the pre‑treatment group were significantly increased compared to those in the post‑treatment and healthy control groups. Moreover, the multivariate analysis revealed that the levels of ALT and HBV‑DNA in the serum were significantly positively correlated with PD‑1 expression levels. In conclusion, the expression levels of these costimulatory molecules reflect the immune dysfunction of T cells in patients with CHB and, combined with T‑cell subset analysis may be used as a novel evaluation system of immune function in patients with HBV infection.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Wursthorn K, Wedemeyer H and Manns MP: Managing HBV in patients with impaired immunity. Gut. 59:1430–1445. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Rehermann B: Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J Exp Med. 191:1263–1268. 2000. View Article : Google Scholar : PubMed/NCBI

3 

Frebel H, Richter K and Oxenius A: How chronic viral infections impact on antigen-specific T-cell responses. Eur J Immunol. 40:654–663. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Klein J and Sato A: The HLA system. First of two parts. N Engl J Med. 343:702–709. 2000. View Article : Google Scholar : PubMed/NCBI

5 

Jonuleit H, Schmitt E, Schuler G, Knop J and Enk AH: Induction of interleukin 10 producing, nonproliferating CD4+T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 192:1213–1322. 2000.PubMed/NCBI

6 

Dhodapkar MV, Steinman RM, Krasovsky J, Munz C and Bhardwaj N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med. 193:233–238. 2001. View Article : Google Scholar : PubMed/NCBI

7 

Barboza L, Salmen S, Peterson DL, et al: Altered T cell costimulation during chronic hepatitis B infection. Cell Immunol. 257:61–68. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Shi B, Du X, Wang Q, et al: Increased PD-1 on CD4+CD28−T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases. Metabolism. 62:778–785. 2013.

9 

Shi Qin, Gu Yanzheng, Cai Yan, et al: Human mesenchymal stem cell-differentiated osteoblast derived from bone marrow increases its immunogenicity by upregulating the expressions of co-stimulatory molecules. Bone. 47:5385–5458. 2010.

10 

Zamoyska R: CD4 and CD8: modulators of T-cell receptor recognition of antigen and of immune responses? Curr Opin Immunol. 10:82–87. 1998. View Article : Google Scholar : PubMed/NCBI

11 

Bang G, Kim KH, Guarnieri M, et al: Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion. Virology. 332:216–224. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Liu XH, Zheng SJ, Zu KJ, et al: A retrospective study of clinical and pathological spectrum in 91 patients with chronic severe hepatitis B. Chin J Hepato. 18:721–725. 2010.PubMed/NCBI

13 

Miyaaki H, Zhou H, Ichikawa T, et al: Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected paticnts. Liver Int. 29:702–707. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Milich DR: Influence of T-helper cell subsets and crossgulation in hepatitis B virus infection. J Vir Hepat. 4:48–59. 1997. View Article : Google Scholar : PubMed/NCBI

15 

Jiang R, Feng X, Guo Y, et al: T helper cells in patients with chronic hepatitis B virus infection. Chin Med J (Engl). 115:422–424. 2002.PubMed/NCBI

16 

Priimiagi LS, Tefanova VT, Tallo TG, et al: Immune-regulating Thl-and Th2-cytokines in chronic infections caused by hepatitis B and C viruses. Vopr Virusol. 48:37–40. 2003.PubMed/NCBI

17 

Ubaldi V, Gatta L, Pace L, et al: CTLA-4 engagement inhibits Th2 but not Thl cell polarization. Clin Dev Immunol. 10:13–17. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Kato T and Nariuchi H: Polarization of naive CD4 T cells toward the Thl subset by CTLA-4 costimulation. J Immunol. 164:3554–3562. 2000. View Article : Google Scholar : PubMed/NCBI

19 

Trautmann L, Janbazian L, Chomont N, Said EA, Gimming S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, Routy JP, Haddad EK and Sekaly RP: Upregulation of PD-1 expression on HIV specific CD8+T cells leads to reversible immune dysfunction. Nat Med. 12:1198–1202. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Urbani S, Amadei B, Tola D, Massari M, Schivazzappa S, Missale G and Ferrari C: PD-1 expression in acute hepatitis C virus (HCV) is associated with HCV-specific CD8 exhaustion. J Virol. 80:11398–11403. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, Bertoletti A and Ferrari C: Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 81:4215–4225. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, Cavallo MC, Silini EM, Andreone P, Missale G and Ferrari C: Antiviral intrahepatic T cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology. 138:682–693. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Maier H, Isogawa M, Freeman GJ and Chisari FV: PD-1: PD-L1 interactions contribute to the functional suppression of virus-specific CD8+T lymphocytes in the liver. J Immunol. 178:2714–2720. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Peng G, Li S, Wu W, Tan X, Chen Y and Chen Z: PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol. 45:963–970. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Kim WR, Flamm SL, Di Bisceglie AM and Bodenheimer HC; Public Policy Committee of the American Association for the Study of Liver Disease. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 47:1363–1370. 2008. View Article : Google Scholar : PubMed/NCBI

26 

Wu W, Shi Y, Li J, Chen F, Chen Z and Zheng M: Tim-3 expression peripheral T cell subsets correlates with disease progression in hepatitis B infection. Virol J. 8:1132011. View Article : Google Scholar : PubMed/NCBI

27 

Jin HT, Anderson AC, Tan WG, et al: Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA. 107:14733–14738. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Li Z, Li N, Zhu Q, et al: Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection. Infect Genet Evol. 14:240–246. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang L, Zhao C, Peng Q, Shi J and Gu G: Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection. Biomed Rep 2: 270-274, 2014.
APA
Wang, L., Zhao, C., Peng, Q., Shi, J., & Gu, G. (2014). Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection. Biomedical Reports, 2, 270-274. https://doi.org/10.3892/br.2014.217
MLA
Wang, L., Zhao, C., Peng, Q., Shi, J., Gu, G."Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection". Biomedical Reports 2.2 (2014): 270-274.
Chicago
Wang, L., Zhao, C., Peng, Q., Shi, J., Gu, G."Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection". Biomedical Reports 2, no. 2 (2014): 270-274. https://doi.org/10.3892/br.2014.217
Copy and paste a formatted citation
x
Spandidos Publications style
Wang L, Zhao C, Peng Q, Shi J and Gu G: Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection. Biomed Rep 2: 270-274, 2014.
APA
Wang, L., Zhao, C., Peng, Q., Shi, J., & Gu, G. (2014). Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection. Biomedical Reports, 2, 270-274. https://doi.org/10.3892/br.2014.217
MLA
Wang, L., Zhao, C., Peng, Q., Shi, J., Gu, G."Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection". Biomedical Reports 2.2 (2014): 270-274.
Chicago
Wang, L., Zhao, C., Peng, Q., Shi, J., Gu, G."Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection". Biomedical Reports 2, no. 2 (2014): 270-274. https://doi.org/10.3892/br.2014.217
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team